© 2021 MJH Life Sciences and Cancer Network. All rights reserved.
© 2021 MJH Life Sciences™ and Cancer Network. All rights reserved.
Dr. Rebecca Previs reviews first line treatment options for patients with advanced ovarian cancer.
April 1st 2021
An expert in gynecologic oncology talks about the role of bevacizumab in the front-line management of advanced ovarian cancer.
Dr. Rebecca Previs explains the importance of somatic and germline testing in guiding first line treatment selection in women with advanced ovarian cancer.
April 8th 2021
An expert oncologist reviews therapeutic options for front line maintenance in advanced ovarian cancer.